TD Cowen Reiterates Buy Rating on Cullinan Oncology Inc. (CGEM)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street dips as higher yields, rising oil prices mark shaky start to SeptemberÂ
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
BTIG Reiterates Buy Rating on Cullinan Oncology Inc. (CGEM)
September 18, 2024 6:20 AM EDTBTIG analyst Julian Harrison reiterated a Buy rating and $30.00 price target on Cullinan Oncology Inc. (NASDAQ: CGEM).
The analyst comments "Mgmt. has received regulatory approval to initiate the global Phase 1 trial for SLE in Australia. In the US, we expect the IND to open in ~30 days, assuming no further inquiries from the... More
